[ad_1] Akcea Therapeutics (AKCA): The company maintained a gross margin of 87.70%. The corporate ownership of the company is 26.40% while the ownership of Insiders is 75.50%. The company maintained its return on investment (ROI) to -65.50% in the previous 12 months and was able to maintain the return on …
Read More »Akcea Therapeutics (AKCA) – Bitcoin & Stock Journal
